WhiteLab Genomics vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionWhiteLab GenomicsIsomorphic Labs
PricingContactContact
Target UserGene therapy researchers, biotech/pharma, academic labsLarge pharma companies, big pharma partnerships
Core TechnologyAI-predicted AAV capsid design, promoter optimization, guide RNA designAlphaFold-based protein-ligand predictive models, generative molecule design
Delivery FocusAAV, LV, non-viral delivery optimizationNot specified (small molecule/biological drug design)
Partnership ModelCollaborations with Sanofi, Cytiva, DebiopharmExclusive large-scale pharma partnerships (Novartis, J&J)

If you need AI-guided design for gene therapy constructs (capsids, promoters, guides) with in silico validation and collaborative workspaces, WhiteLab Genomics is the targeted choice. For large-scale small molecule drug discovery powered by AlphaFold and deep pharma partnerships, Isomorphic Labs is the more powerful but less accessible platform. Choose based on whether your focus is genomic medicine or traditional small molecule drug development.

WhiteLab Genomics
WhiteLab Genomics

AI platform that designs and predicts molecular constructs for gene and RNA therapies before they reach the lab

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
13 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
—
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
AI-designed AAV capsid variants with novel tropisms
Promoter optimization for cell-type specificity
Guide RNA design for CRISPR and gene editing therapies
Off-target prediction for gene editing
Toxicity prediction for molecular constructs
Delivery vehicle optimization across AAV, lentivirus, and nanoparticles
Target receptor identification for viral vectors
Payload design for gene and RNA-based therapies
Non-viral vector design for solid tumors and in vivo CAR-T
Cell therapy support including CAR design
Bioproduction optimization for AAV and lentivirus programs
In silico construct validation before synthesis
In vivo validated AI-designed vectors for CNS brain delivery after IV injection
Collaborative project workspaces for computational and wet-lab teams
Access to proprietary curated biological datasets
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO

What real users say: WhiteLab Genomics vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

WhiteLab Genomics

5 mentions across 1 sources · 50% positive — mixed (averaged across 1 source)

YouTube

What users praise

  • • AI-driven design for AAV capsids, promoters, and guide RNAs improves accuracy.
  • • Partnerships with Sanofi, Cytiva, and Debiopharm validate technology.
  • • Covers multiple modalities: AAV, lentivirus, and nanoparticles.
  • • In vivo brain delivery demonstration is a significant milestone.

What frustrates them

  • • Lack of independent user reviews undermines trust and assessment.
  • • No transparent pricing; requires contact, which may deter small labs.
  • • Advanced skill level needed; not accessible to beginners.
  • • No mention of integrations or API, limiting workflow flexibility.

Researched Aug 4, 2026

Isomorphic Labs

No verifiable community signal. We scanned public discussion on Oct 7, 2026 and found posts matching the name “Isomorphic Labs”, but could not establish that they are about this product rather than something else sharing its name. Rather than publish a score built on the wrong subject, we publish none.

Who should pick which

  • Gene therapy startup optimizing AAV capsids
    Pick: WhiteLab Genomics

    AI-predicted capsid design and promoter optimization are core to its platform; features directly address AAV engineering.

  • Large pharma with multi-billion dollar drug pipeline
    Pick: Isomorphic Labs

    Partnership model and AlphaFold-based predictive power fit large-scale, resource-intensive programs; J&J collaboration validates this.

  • Academic lab studying CRISPR therapies
    Pick: WhiteLab Genomics

    Provides guide RNA design, off-target prediction, and in silico validation—essential for academic gene editing research.

  • CRO offering nucleic acid therapy validation
    Pick: WhiteLab Genomics

    Collaborative workspaces and integration with lab data formats support CRO workflows for gene therapy validation.

Frequently Asked Questions

WhiteLab Genomics vs Isomorphic Labs: which should you choose?

If you need AI-guided design for gene therapy constructs (capsids, promoters, guides) with in silico validation and collaborative workspaces, WhiteLab Genomics is the targeted choice. For large-scale small molecule drug discovery powered by AlphaFold and deep pharma partnerships, Isomorphic Labs is the more powerful but less accessible platform. Choose based on whether your focus is genomic medicine or traditional small molecule drug development.

Which platform is better for designing AAV capsids?

WhiteLab Genomics offers AI-predicted AAV capsid design with novel tropisms; Isomorphic Labs does not offer this feature.

Can I use Isomorphic Labs for CRISPR guide RNA design?

No. Isomorphic Labs focuses on small molecule drug discovery, not gene editing tools.

Which tool is more affordable?

Both use contact-based pricing. WhiteLab may have lower entry barriers for smaller teams, while Isomorphic targets large pharma partnerships with significant investment.

Does WhiteLab Genomics support non-viral delivery?

Yes, it includes delivery vehicle optimization for AAV, LV, and non-viral methods.

Is Isomorphic Labs based on AlphaFold?

Yes. Isomorphic Labs was spun out of DeepMind and uses AlphaFold as a foundation for protein-ligand interaction predictions.

Which platform has public partnerships?

WhiteLab partnered with Sanofi, Cytiva, Debiopharm. Isomorphic partnered with Novartis and Johnson & Johnson (2026).

Can I get a free trial for either platform?

No. Both require contacting sales; no public self-service tiers.

Which platform is better for AI drug discovery collaboration?

Isomorphic Labs is structured for deep pharma collaborations; WhiteLab Genomics also supports collaborative workspaces but is more product-oriented.

More WhiteLab Genomics or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026